Cite
MLA Citation
Delphine El Mehdi et al.. “APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria.” Molecular immunology, vol. 89, n.d., pp. 115–. http://access.bl.uk/ark:/81055/vdc_100049903415.0x00002e